Heart Transplantation in a 78-year-old Patient

78세 고령에서의 심장이식

  • Park, Byung-Joon (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Pyo-Won (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Choi, Seon-Uoo (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Sung, Ki-Ick (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Ji-Hyuk (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 박병준 (성균관대학교 의과대학 삼성서울병원 흉부외과학교실) ;
  • 박표원 (성균관대학교 의과대학 삼성서울병원 흉부외과학교실) ;
  • 최선우 (성균관대학교 의과대학 삼성서울병원 흉부외과학교실) ;
  • 성기익 (성균관대학교 의과대학 삼성서울병원 흉부외과학교실) ;
  • 양지혁 (성균관대학교 의과대학 삼성서울병원 흉부외과학교실)
  • Published : 2008.10.05

Abstract

Advanced age is known to be a risk factor for early mortality after heart transplantation and is considered to be a relative contraindication. However, recent studies have shown that there are no significant differences in early and midterm survival rates between older and younger recipients. With rising life expectancy and improvements in medical support, the demand for heart transplantation in elderly patients continues to grow. We present a successful case of heart transplantation in a 78-year-old patient.

고령은 심장이식 후 사망의 위험인자로 상대적 금기로 알려져 왔으나 최근 일부 연구에 의하면 젊은 환자에 비교하여 초기 및 중기 생존률의 통계적 차이가 없다고 보고되고 있다. 평균 수명의 연장과 보전적 투약 치료의 발전으로 심장이식수술이 유일한 치료로서 합당한 고령의 말기 심질환 환자가 증가하는 추세이다. 본 저자들은 78세의 고령의 환자에게 성공적으로 심장이식수술을 시행하였기에 그 사례를 보고하는 바이다.

Keywords

References

  1. Favaloro R, Diez M, Bertolotti A, et al. Orthotopic heart transplantation in elderly patients: a 10-year experience at single center. Transplant Proc 2003;36:1692-4
  2. Perraira JR, Segovia J, Fuentes R, et al. Differential characteristics of heart transplantation in patients older than 60 years. Transplant Proc 2003;35:1959-61 https://doi.org/10.1016/S0041-1345(03)00650-X
  3. Demers P, Moffatt S, Oyer PE, et al. Long-term results of heart transplantation in patients older than 60 years. J Thorac Cardiovasc Surg 2003;126:224-31 https://doi.org/10.1016/S0022-5223(03)00055-2
  4. Weiss ES, Nwakanma LU, Patel ND, et al. Ouycomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of UNOS database. J Heart Lung Transplant 2008;27:184-91 https://doi.org/10.1016/j.healun.2007.11.566
  5. Sack FU, Kristen A, Goldschmidt H, et al. Treatment option for cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. Eur J Cardiothorac Surg 2008;33: 257-62 https://doi.org/10.1016/j.ejcts.2007.10.025